- Citations, last 5 years
- 2 490
- Works, last 5 years
- 440
- h-index
- 112
- Scientists listed
- 0
- Grants since 2016
- 3 213
Grants received
2024–2027 · fellowship · F31
A Mechanoimmunological Basis for Metastatic Site Preference
Yassmin Elbanna · Kettering University · funded by National Institutes of Health
2024–2029 · career development · K08
Understanding mechanisms of impaired immunity in the AML bone marrow
Susan E Dewolf · Kettering University · funded by National Institutes of Health
2024–2029 · research · R01
Theranostic DLL3/PSMA-bi-specific CAR-T cells for prostate cancer therapy
Vladimir Ponomarev · Kettering University · funded by National Institutes of Health
2024–2026 · research · R01
Understanding lung cancer genomics in patients of African ancestry
Jian Carrot-Zhang · Kettering University · funded by National Institutes of Health
2024–2028 · research · R01
Structural basis of eukaryotic clamp loading
Richard Kevin Hite · Kettering University · funded by National Institutes of Health
2024–2026 · research · R01
Targeting the ROR2/p-GSK3bS9 pathway to suppress metastasis in SMARCA4-deficient lung adenocarcinoma
David R Jones · Kettering University · funded by National Institutes of Health
2024–2029 · research · R01
Neoadjuvant Tucatinib plus Trastuzumab in HER2-amplified Locally Advanced Rectal Cancer
Andrea Cercek · Kettering University · funded by National Institutes of Health
2024–2025 · career development · K99
Developing a communication support intervention for cancer caregivers in emerging and young adulthood
Amanda Kastrinos · Kettering University · funded by National Institutes of Health
2024–2029 · research · R01
Maternal B cells in health and disease.
Gabrielle A Rizzuto · Kettering University · funded by National Institutes of Health
2024–2029 · research · R01
Tuning KITv CAR T cells for the solid tumor environment
Prasad S. Adusumilli · Kettering University · funded by National Institutes of Health
2024–2029 · research · R37
Circulating metabolites as novel risk biomarkers for gastric cancer: a large multi-center prospective investigation
Xiang Shu · Kettering University · funded by National Institutes of Health
2024–2026 · fellowship · F31
Investigating the role of L-2-hydroxyglutarate in helper T cell differentiation and function
Thomas Francis Mcnamara · Kettering University · funded by National Institutes of Health
2024–2028 · research · R01
Phase II trial of avutometinib plus defactinib in RAF dimer-driven thyroid cancers
Alan L. Ho · Kettering University · funded by U.S. Food and Drug Administration
2024–2029 · research · R01
Investigating hypoxia as a determinant of malignant fates in pancreas cancer
Michael Hemann · Kettering University · funded by National Institutes of Health
2024–2029 · research · R01
Enhanced Pain Coping in Cancer (EPIC)
Eric Lee Garland · Kettering University · funded by National Institutes of Health
2024–2025 · career development · K99
Unraveling the ecology of intestinal fungal expansion in immunocompromised patients through computational modeling and machine learning
Chen Liao · Kettering University · funded by National Institutes of Health
2024–2027 · research · R00
Molecular recording to understand the determinants of cell fate transitions in early development
Junhong Choi · Kettering University · funded by National Institutes of Health
2024–2029 · research · R01
Decoding cell states and tissue morphogenesis in the early mammalian embryo
Anna-Katerina Hadjantonakis · Kettering University · funded by National Institutes of Health
2024–2025 · career development · K99
Targeting Pancreatic Cancer Senescence with ImmunoPET
Edwin Charles Pratt · Kettering University · funded by National Institutes of Health
2024–2029 · research · R01
RSMI HEALS
Francesca M Gany · Kettering University · funded by National Institutes of Health
2024–2028 · research · R01
In vivio single-cell analysis of dynamic cell behaviors
Anna-Katerina Hadjantonakis · Kettering University · funded by National Institutes of Health
2024–2029 · cooperative agreement · U01
Desmoplastic small round cell tumor: harnessing new insights and new models
Marc Ladanyi · Kettering University · funded by National Institutes of Health
2024–2029 · research · R37
Reproducible and Accurate PD-L1 Immunohistochemistry Biomarker Quantification Using Virtual Multiplex Immunofluorescence Restaining
Saad Nadeem · Kettering University · funded by National Institutes of Health
2024–2029 · program · P01
Leveraging Observational (Real World) Data to Advance Precision Oncology
Charles L. Sawyers · Kettering University · funded by National Institutes of Health
2024–2027 · career development · K99
Dissecting FOSL1-mediated lineage plasticity and resistance to androgen receptor signaling inhibition in prostate cancer
Chen Khuan Wong · Kettering University · funded by National Institutes of Health
2024–2029 · research · R37
Circulating metabolites as novel risk biomarkers for gastric cancer: a large multi-center prospective investigation
Xiang Shu · Kettering University · funded by National Institutes of Health
2024–2029 · cooperative agreement · U01
Anti-ceramide Ab Preserves Intestinal Stem Cells and Prevents GI-ARS and GI-DEARE
Richard N Kolesnick · Kettering University · funded by National Institutes of Health
2024–2029 · research · R01
Decreasing Cardiometabolic Risk in Survivors of Childhood Cancer: Survivors engaged in Time-Restricted EatiNG after THerapy (STRENGTH)
Danielle Friedman · Kettering University · funded by National Institutes of Health
2024–2026 · career development · K99
Quantitatively predicting drug-resistant mutations to improve precision oncology
Sukrit Singh · Kettering University · funded by National Institutes of Health
2024–2026 · fellowship · F99
Identifying and Targeting Drivers of Impaired Translation in Tumor-infiltrating CD8+ T-cells.
Yan-Ting Chen · Kettering University · funded by National Institutes of Health
2024–2026 · grant · OT2
eDyNAmiC (extrachromosomal DNA in Cancer) - Understanding the biology of ecDNA generation and action, and developing new ways to target these mechanisms in cancer
Andrea Ventura · Kettering University · funded by National Institutes of Health
2024–2026 · career development · K99
WNK1-dependent macropinocytosis mediates emergency myelopoiesis
Alissa Jane Trzeciak · Kettering University · funded by National Institutes of Health
2024–2026 · program · P20
Addressing cancer disparities in Nigeria through Immuno-oncology Research – The NOLA Program
T Peter Kingham · Kettering University · funded by National Institutes of Health
2024–2026 · research · R03
PSMA ligand radiosensitizers to improve the therapeutic index of external beam radiotherapy for prostate cancer
Daniel Higginson · Kettering University · funded by National Institutes of Health
2024–2026 · program · P20
Addressing cancer disparities in Nigeria through Immuno-oncology Research – The NOLA Program
T Peter Kingham · Kettering University · funded by National Institutes of Health
2024–2029 · research · R01
Trial of Meaning Centered Psychotherapy for Mexican Patients with Advanced Cancer
Rosario Costas-Muniz · Kettering University · funded by National Institutes of Health
2024–2029 · research · R01
Mechanistic basis for endoplasmic reticulum-driven cytoprotection by selective autophagy in neurons
Alban Ordureau · Kettering University · funded by National Institutes of Health
2024–2029 · career development · K08
Integrating Electronic Patient-Reported Outcomes into Discharge Planning
Jennifer R Cracchiolo · Kettering University · funded by National Institutes of Health
2024–2028 · research · R01
Characterizing the theranostic potential of DLL3-targeting agents in high-grade neuroendocrine carcinomas of the lung and prostate
Lisa Bodei · Kettering University · funded by National Institutes of Health
2024–2026 · program · P20
Research Project
T Peter Kingham · Kettering University · funded by National Institutes of Health